Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

36.32
-0.0291-0.08%
Post-market: 36.350.0291+0.08%16:10 EDT
Volume:180
Turnover:7K
Market Cap:19.07M
PE:- -
High:36.32
Open:36.35
Low:36.32
Close:36.35
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:4.66
T/O Rate:0.03%
Dividend:0.11
Dividend Rate:0.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Nokia announces commercial agreement with BeeHealthy

TIPRANKS
·
Sep 03

Yinchuan Market Regulators Roll Out Comprehensive Measures to Implement Revised Medical Device Production Quality Standards

Deep News
·
Sep 03

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Sep 03

Nokia and BeeHealthy bring network-based verification to digital healthcare

GlobeNewswire
·
Sep 03

PainChek to Brief Investors on Global AI Pain Platform Expansion and U.S. Growth Strategy

TIPRANKS
·
Sep 03

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 03

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Inventiva announces last patient visit in NATiV3 trial

TIPRANKS
·
Sep 03

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Reuters
·
Sep 03

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Sep 03

Sector Update: Healthcare

MT Newswires Live
·
Sep 03

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live
·
Sep 02

LIVE Markets-Wall Street Starts Slow, Dow Leads

Reuters
·
Sep 02

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

TradingKey
·
Sep 02

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

Dow Jones
·
Sep 02

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Sep 02

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Sep 02

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Deep News
·
Sep 02

Johnson & Johnson assumed with a Buy at UBS

TIPRANKS
·
Sep 02

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS
·
Sep 02